These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
491 related items for PubMed ID: 7691959
21. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex. Kochi SK, Johnson RC, Dalmasso AP. J Immunol; 1991 Jun 01; 146(11):3964-70. PubMed ID: 2033266 [Abstract] [Full Text] [Related]
22. CD59 blocks not only the insertion of C9 into MAC but inhibits ion channel formation by homologous C5b-8 as well as C5b-9. Farkas I, Baranyi L, Ishikawa Y, Okada N, Bohata C, Budai D, Fukuda A, Imai M, Okada H. J Physiol; 2002 Mar 01; 539(Pt 2):537-45. PubMed ID: 11882685 [Abstract] [Full Text] [Related]
23. Identity of the segment of human complement C8 recognized by complement regulatory protein CD59. Lockert DH, Kaufman KM, Chang CP, Hüsler T, Sodetz JM, Sims PJ. J Biol Chem; 1995 Aug 25; 270(34):19723-8. PubMed ID: 7544344 [Abstract] [Full Text] [Related]
24. Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Meri S, Morgan BP, Davies A, Daniels RH, Olavesen MG, Waldmann H, Lachmann PJ. Immunology; 1990 Sep 25; 71(1):1-9. PubMed ID: 1698710 [Abstract] [Full Text] [Related]
26. Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis. Meri S, Lehto T, Sutton CW, Tyynelä J, Baumann M. Biochem J; 1996 Jun 15; 316 ( Pt 3)(Pt 3):923-35. PubMed ID: 8670172 [Abstract] [Full Text] [Related]
28. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells. Hakulinen J, Meri S. Lab Invest; 1994 Dec 15; 71(6):820-7. PubMed ID: 7528832 [Abstract] [Full Text] [Related]
29. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly. Podack ER, Tschoop J, Müller-Eberhard HJ. J Exp Med; 1982 Jul 01; 156(1):268-82. PubMed ID: 6177822 [Abstract] [Full Text] [Related]
34. The role of the C9b domain in the binding of C9 molecules to EAC1-8 defined by monoclonal antibodies to C9. Yoden A, Moriyama T, Inoue K, Inai S. J Immunol; 1988 Apr 01; 140(7):2317-21. PubMed ID: 3351301 [Abstract] [Full Text] [Related]
39. Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes. Bhakdi S, Käflein R, Halstensen TS, Hugo F, Preissner KT, Mollnes TE. Clin Exp Immunol; 1988 Dec 16; 74(3):459-64. PubMed ID: 2466593 [Abstract] [Full Text] [Related]
40. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes. Stewart JL, Monahan JB, Brickner A, Sodetz JM. Biochemistry; 1984 Aug 28; 23(18):4016-22. PubMed ID: 6487588 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]